Consolidated Statement Of Cash Flows

PhoenixBio Co.,Ltd. - Filing #7556538

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
413,815,000 JPY
510,644,000 JPY
-393,002,000 JPY
-160,891,000 JPY
Depreciation
23,700,000 JPY
86,238,000 JPY
Impairment losses
JPY
265,027,000 JPY
Interest expenses
3,072,000 JPY
952,000 JPY
Increase (decrease) in provision for bonuses
4,546,000 JPY
JPY
Foreign exchange losses (gains)
-5,793,000 JPY
-5,951,000 JPY
Subtotal
277,362,000 JPY
12,751,000 JPY
Income taxes paid
-12,118,000 JPY
-4,175,000 JPY
Decrease (increase) in inventories
-105,870,000 JPY
-19,018,000 JPY
Increase (decrease) in trade payables
2,344,000 JPY
-4,577,000 JPY
Net cash provided by (used in) operating activities
277,491,000 JPY
16,398,000 JPY
Other, net
506,000 JPY
3,190,000 JPY
Interest and dividends received
2,221,000 JPY
203,000 JPY
Interest paid
-3,072,000 JPY
-955,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-6,835,000 JPY
-6,771,000 JPY
Net cash provided by (used in) investing activities
-156,340,000 JPY
-6,975,000 JPY
Purchase of investment securities
-136,114,000 JPY
JPY
Other, net
-7,857,000 JPY
-203,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
JPY
-2,481,000 JPY
Net cash provided by (used in) financing activities
86,630,000 JPY
-34,658,000 JPY
Repayments of lease liabilities
-56,300,000 JPY
-30,161,000 JPY
Effect of exchange rate change on cash and cash equivalents
22,034,000 JPY
22,930,000 JPY
Net increase (decrease) in cash and cash equivalents
229,815,000 JPY
-2,305,000 JPY
Cash and cash equivalents
1,555,323,000 JPY
1,325,507,000 JPY
1,327,813,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.